(1-3)(1-6)-D-glucans Modulate Immune Status and Blood Glucose Levels in Dogs.

Simple item page
dc.contributor.authorVetvicka, Vaclav
dc.contributor.authorOliveira, Carlos
dc.date.accessioned2015-09-14T05:53:05Z
dc.date.available2015-09-14T05:53:05Z
dc.date.issued2014-04
dc.description.abstractAims: The objective of this study is to evaluate the effects of adding two different glucans coded as BGO1 and BGO2 into commercial feed of dogs. Study Design: We measured changes in phagocytosis, levels of IL-2 in blood, antibody formation and level of blood sugar (normal homeostasis and experimentally-induced hyperglycaemie with streptozotocin). Place and Duration of Study: Department of Pathology, University of Louisville, and Department of Research and Development, Biorigin, June 2012 and May 2013. Methodology: The technique employing phagocytosis of synthetic polymeric microspheres was used for evaluation of phagocytic activity. IL-2 production was evaluated in serum by an ELISA kit. Formation of antibodies was tested using ovalbumin as an antigen, level of specific antibodies was measured by ELISA. Blood sugar evaluation was done both in normal animals and in animals with experimentally-induced hyperglycaemie. The level of glucose in serum was measured by Antech Diagnostics. Results: In phagocytosis, both glucans significantly (P ≤0.05 level) increased the phagocytic activity of blood monocytes and neutrophils. Both glucans were active in IL-2 tests, but BG01 activity was 160% of that of BG02. Similar data were achieved in evaluation of effects on antibody response – BG01 reached OD of 0.717, whereas BG02 reached OD 0.411. Blood sugar evaluations showed no effect of glucan on normal dogs, but significant (P ≤0.05 level) reduction in dogs with hyperglycaemie (both glucans showed same activity). Conclusion: Our data showed that both glucans had significant immunomodulating effects in immune reactions in the dog model, strongly suggesting that supplementation of feed with these glucans results in improvement of biological and immunological conditions of dogs.en_US
dc.identifier.citationVetvicka Vaclav, Oliveira Carlos. (1-3)(1-6)-D-glucans Modulate Immune Status and Blood Glucose Levels in Dogs. British Journal of Pharmaceutical Research. 2014 Apr; 4(8): 981-991.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/163420
dc.language.isoenen_US
dc.source.urihttps://sciencedomain.org/abstract/3945en_US
dc.subjectDogsen_US
dc.subjectglucanen_US
dc.subjectphagocytosisen_US
dc.subjectimmunityen_US
dc.subjectblood sugaren_US
dc.subjectIL-2en_US
dc.subjectdiabetesen_US
dc.title(1-3)(1-6)-D-glucans Modulate Immune Status and Blood Glucose Levels in Dogs.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
bjpr2014v4n8p981.pdf
Size:
709.51 KB
Format:
Adobe Portable Document Format
Description:
Original research article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal of Pharmaceutical Research International